In a closely watched patent battle, the U.S. Supreme Court on Thursday unanimously ruled against California-based drugmaker Amgen, affirming a lower court’s decision that Amgen’s French rival Sanofi didn’t infringe on patents on a cholesterol-lowering antibody drug. The long-running feud involves two rival drugs: Praluent, developed by Sanofi and New York partner Regeneron and greenlit…
Supreme Court Rejects Teva Challenge to $235 Million GSK Award in Patent Dispute
WASHINGTON—The U.S. Supreme Court on Monday declined to hear Teva Pharmaceuticals USA Inc.’s challenge to a $235 million award to GlaxoSmithKline LLC in a patent dispute over generic drugs involving a heart medication. The justices turned away Israel-based Teva’s appeal of a lower court’s ruling reinstating the jury award for U.K.-based GSK. The case involves…
Google Wins US Patent Trial Over Data-Retrieval Technology
Alphabet’s Google LLC won a jury trial on Tuesday in a long-running patent lawsuit in Delaware federal court over features in Google’s smartphones and apps. The jury decided that Luxembourg-based patent owner Arendi SARL’s patent was invalid and that Google did not infringe it, according to the verdict made public on Wednesday. Attorneys for Arendi…
Textron Wins $279 Million Verdict in US Patent Case Against Chinese Drone Maker DJI
U.S. aerospace company Textron Inc. won a $279 million verdict on Friday against Chinese drone maker DJI Technology, persuading a federal jury in Waco, Texas that DJI willfully infringed its patents. The jury agreed with subsidiary Textron Innovations Inc after a week-long trial that DJI’s drones violate its rights in two patents related to drone…
Apple Wins Reversal of $502 Million VirnetX Patent Infringement Verdict
Apple Inc. on Friday convinced a U.S. appeals court to throw out a $502 million verdict for patent licensing company VirnetX Inc. in a long-running fight over internet privacy technology. The U.S. Court of Appeals for the Federal Circuit said the verdict could not stand after the U.S. Patent Trial and Appeal Board canceled the…
BlackBerry Signs up to $900 Million Patent Deal After Sale to Catapult Collapses
BlackBerry Ltd. said on Tuesday it would sell patents, primarily related to its mobile devices, for up to $900 million after the Canadian software company scrapped an earlier deal with Catapult IP Innovations Inc.. Malikie Innovations Ltd. will buy the patents and pay $170 million in cash on deal closing, and another $30 million three…
Judge Rejects Request From Moderna, Moving Key COVID-19 Vaccine Case to Discovery
March 13, 2023
admin
AMERICABusiness & MarketsBusinesses in COVID-19CCP VirusCOVID-19JudiciaryModernapatentUSUS NewsVaccineVaccines & Safety
0 Comment
A key COVID-19 vaccine case is moving to discovery after a U.S. judge rejected a bid by Moderna to dismiss some of the patent infringement claims against it. Moderna and the U.S. government, which backed the company, failed to prove that claims involving the company’s COVID-19 vaccine contract with the government should be dismissed, U.S. District…
Ford Could ‘Lock Out’ Vehicle Owners for Missing Loan Payments Under New Patent
American automobile manufacturer Ford has filed a patent regarding a repossession system that can automatically lock out vehicles in case owners do not make auto loan payments in time, and even move autonomous vehicles to a place of its choosing. The patent application (pdf) pertains to “systems and methods to repossess a vehicle.” According to…
Apple Wins Appeal to Keep $308 Million US Patent Verdict at Bay
A U.S. appeals court on Friday affirmed a decision to throw out a $308.5 million jury verdict against Apple Inc. for allegedly infringing a patent related to digital rights management. The U.S. Court of Appeals for the Federal Circuit in Washington, D.C., upheld an East Texas federal judge’s ruling that Personalized Media Communications LLC’s patent…
How Effective Is Your Cancer Medication? The Industry Might Not Even Know
August 27, 2022
admin
Brightcancerdrug patentsFDAhealthHealth 1+1Health ConditionsHealth SciencemedicineoncologypatentU.S. Food and Drug AdministrationUSUS News
0 Comment
Cancer is the second leading cause of death in the United States, right on the heels of heart disease. In developed countries, the general consensus is that if you do not die of heart disease, then the next likely event is cancer. In fact, most health experts expect that everyone will eventually develop, and likely…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`